Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin ExpansionInfant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market Share Gains1; Third Quarter 2024 Infant formula Net Sales Growth of +3% Compared to the Prior Year Quarter, +58% SequentiallyReaffirms Fiscal 2024 Adjusted EPS OutlookDUBLIN, Nov. 6, 2024 /PRNewswire/ --Third Quarter 2024 Highlights: Net sales of $1.1 billion dec ...